NasdaqGS:ARWRBiotechs
Insiders Could Have Profited By Holding onto Arrowhead Pharmaceuticals Shares Despite 23% Drop
Despite the fact that Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) value has dropped 23% in the last week insiders...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.